Variables entered | PCS | Â | Â | MCS | Â | Â | CLDQ | Â | Â |
---|---|---|---|---|---|---|---|---|---|
 | β(SE) | P | b | β(SE) | P | b | β(SE) | P | b |
Treatment duration (<8Â weeks as reference) | Â | Â | Â | Â | Â | Â | Â | Â | Â |
9–16 weeks | -9.38(2.69) | 0.00 | -0.33 | 0.66(2.81) | 0.82 | 0.02 | -0.32(0.22) | 0.16 | -0.15 |
>17Â weeks | -3.83(2.88) | 0.19 | -0.13 | 1.56(3.00) | 0.60 | 0.05 | 0.09(0.24) | 0.72 | 0.04 |
Monthly income (≤NT$10,000 as reference) |  |  |  |  |  |  |  |  |  |
>NT$30,000 | 8.47(3.54) | 0.02 | 0.33 | 8.79(3.69) | 0.02 | 0.35 | 0.68(0.29) | 0.02 | 0.34 |
NT$10,001 ~ 30000 | 5.69(3.39) | 0.10 | 0.19 | 7.13(3.54) | 0.05 | 0.24 | 0.37(0.28) | 0.19 | 0.16 |
Gender (female as reference) | 4.39(2.44) | 0.08 | 0.18 | 4.80(2.54) | 0.06 | 0.20 | 0.43(0.20) | 0.04 | 0.23 |
R2 | 0.28 | Â | Â | 0.16 | Â | Â | 0.16 | Â | Â |